| Section: Retina Diseases |
| Chairperson: B. Kuppermann |
| Exudative AMD |
Back To Section List |
| Chairpersons: Peter K. Kaiser, USA, Stephan Michels, Austria |
Cand5 siRNA for CNV/AMD
Barry Kuppermann, USA |
A double-masked, placebo-controlled, dose escalation, phase 1 study of intravenous VEGF trap in patients with neovascular age-related macular degeneration
Quan Dong Nguyen, USA |
Avastin for CNV/AMD
Stephan Michels, Germany |
Macugen for CNV/AMD
Jordi Mones, Spain |
Combretastatin A4 phosphate for the treatment of AMD
Quan Dong Nguyen, USA |
Squalamine for the treatment of AMD
Edgar Thomas, USA |
AdPEDF
Tim Stout, USA |
Small molecules (TKIs) for AMD
Shiyin Yee, USA |
siRNA for CNV/AMD
Peter Kaiser, USA |
Integrin antagonism in the treatment of Exudative AMD
Jeff Heier, USA |
Science of VEGF and its implications for the treatment of AMD
Barrett Katz, USA |
Lucentis for CNV/AMD
Ursula Schmidt-Erfurth, Austria |
Retaane for CNV/AMD
Peter Kaiser, USA |
Angiosyn class of molecules for retina diseases
Marty Friedlander, USA |
| |
| Dry AMD |
Back To Section List |
Rheophoresis for AMD
David Boyer, USA |
Nutritional therapy for AMD
Michael J. Cooney, USA |
Genistein for AMD
Eugene de Juan, USA |
Retinoids for AMD
Eugene de Juan, USA |
The role of atherosclerosis in the pathogenesis of AMD
Ephraim Friedman, USA |
| |
New Approaches to the Treatment of CNV/AMD:
New PDT and Combination Therapy |
Back To Section List |
| Chairperson: Salvatore Grisanti, Germany |
PTT/ICG for AMD
Jose A. Cardillo, Brazil |
Photorex for AMD
Garee Thomas, USA |
Triamcinolone + PDT for the treatment of neovascular AMD
Ursula Schmidt-Erfurth, Austria |
Combination therapy for CNV/AMD (Macugen+TA, Macugen+PDT)
Salvatore Grisanti, Italy |
| |
| Macular Edema |
Back To Section List |
| Chairpersons: George A. Williams, USA, Jordi Monés, Spain |
Drug delivery technology
Jose A. Cardillo, Brazil |
The helical coil drug technology for DME
Eugene de Juan, USA |
Macugen for DME
Jordi Mones, Spain |
FA implant uveitis
Carlos Pavesio, UK |
Posurdex for persistent Macular Edema
George Williams, USA |
Lucentis for DME
Ursula Schmidt, Austria |
Intravitreal Triamcinolone for Macular Diseases (DME, CRVO, BRVO)
Ingrid Scott, USA |
New concepts of steroid therapy for retinal disease
Jeff Edelman, USA |
New concepts in the mechanism of action and toxicity of different steroids
Barry Kuppermann, USA |
Intravitreal Injection: Technique for the SCORE and DRCRnet Studies
Ingrid Scott, USA |
FA implant diabetes
Andy Pearson, USA |
| |
| NPDR/PDR/Neuroprotection |
Back To Section List |
| Chairperson:
Edgar L. Thomas, USA |
Octreotide
for diabetic retinopathy
David Boyer, USA |
Vitrase for vitreous hemorrhage and NPDR
Garee Thomas, USA |
Ruboxistaurin for NPDR
Barry Kuppermann, USA |
Retinal neuroprotection
James Burke, USA |
| |
| Vitreolytics/PVR |
Back To Section List |
| Chairperson: Marc de Smet, The Netherlands |
Microplasmin
Marc de Smet, The Netherlands |
Vit 100 for the treatment of proliferative vitreoretinopathy
Naresh Mandava, USA |
Autologous plasmin for all that ails you
George Williams, USA |
